Metanor Resources MEAOD

RE: RE: RE: Raffles'Head

[gahdc]

Re: SoontoRetire:
I certainly hope you are right, my one big worry is that one of the senior companies might snatch MTO away before they reach their full potential. With over 150 anomalies (more than the current 15,000 m drill program can cover) at Barry alone and the existing drill program only half done so far, there is so much potential for a dramatic upgrade in the size of the reserve I think it would be foolish to sell without finding out the full size of Barry, which could end up drawfing Bachelor. Having said that, Bachelor and the connected Hewfran are showing early drill results that indicate that Bachelor could also be much larger in size. I guess I am sensitive to this because this sort of buyout happened to me when Medimune was bought just as they were about to introduce the first fully human monoclonal antibody for cancer, which is now a major drug and first in it's class.

Does anyone have a better idea than me about how the share structure stands?  I know Sprott owns about 15%, much of it  priced at around
.60, and I know Laurentian bank was an early institutional investor. I assume that the smaller investors like me would be more likely to want to hold out and that the big institutional holders might go for a quicker profit. Any comments?